{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:31:43Z","timestamp":1760027503080},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.atherosclerosis.2018.07.032","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T03:53:35Z","timestamp":1532577215000},"page":"148-154","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans"],"prefix":"10.1016","volume":"276","author":[{"given":"Gilbert R.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib1","series-title":"Arteriosclerosis","first-page":"178","article-title":"Experimental atherosclerosis in animals","author":"Anitschkow","year":"1933"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib2","series-title":"Pioneers of Medicine without a Nobel Prize","first-page":"23","article-title":"Nikolai Anitschkow: the birth of the lipid hypothesis of atherosclerosis and coronary heart disease","author":"Steinberg","year":"2014"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib3","first-page":"379","article-title":"Ueber die Veranderungen der Kaninchenaorta bei experimenteller Cholesterinsteatose","volume":"56","author":"Anitschkow","year":"1913","journal-title":"Beitr Pathol Anat"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2018.07.032_bib4","first-page":"178","article-title":"Classics in arteriosclerosis research: on experimental cholesterin steatosis and its significance in the origin of some pathological processes, translated by Mary Z. Pelias, 1913","author":"Anitschkow","year":"1983","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/01.RES.22.2.135","article-title":"Reversibility of atherosclerosis in cholesterol-fed rabbits","volume":"22","author":"Bortz","year":"1968","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0005-2760(82)90263-6","article-title":"Receptor-mediated catabolism and tissue uptake of human low density lipoprotein in the cholesterol-fed, atherosclerotic rabbit","volume":"713","author":"Slater","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1194\/jlr.M019927","article-title":"Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia","volume":"53","author":"Yin","year":"2012","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0022-2275(20)36905-4","article-title":"Three-pool model of the long-term turnover of plasma cholesterol in man","volume":"14","author":"Goodman","year":"1973","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib9","series-title":"The Biology of Cholesterol and Related Steroids","author":"Myant","year":"1981"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1172\/JCI107772","article-title":"The turnover of cholesterol in human atherosclerotic arteries","volume":"54","author":"Jagannathan","year":"1974","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0022-2275(20)38106-2","article-title":"Cholesterol turnover in lipid phases of human atherosclerotic plaque","volume":"23","author":"Katz","year":"1982","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib12","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"2863","article-title":"Familial hypercholesterolemia","author":"Goldstein","year":"2001"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib13","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/hrt.80.6.583","article-title":"Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia","volume":"80","author":"Rallidis","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/01.CIR.98.6.509","article-title":"Evaluation of the aortic root by MRI: insights from patients with homozygous familial hypercholesterolemia","volume":"98","author":"Summers","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jacl.2016.04.006","article-title":"Clinical and molecular characteristics of homozygous familial hypercholesterolemia patients: insights from SAFEHEART registry","volume":"10","author":"Alonso","year":"2016","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib17","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1136\/bmj.291.6510.1671","article-title":"Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange","volume":"291","author":"Thompson","year":"1985","journal-title":"Br Med J Clin Res Ed"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib18","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib19","doi-asserted-by":"crossref","unstructured":"Thompson GR, Griffin M, Bond D, Nicolaides A, Seed. M. Of cholesterol-fed rabbits and LDL receptor-deficient men. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.11.022.","DOI":"10.1016\/j.atherosclerosis.2013.11.022"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-2275(20)41433-6","article-title":"Characterization of mutations in the low density lipoprotein (LDL)-receptor gene in patients with homozygous familial hypercholesterolemia, and frequency of these mutations in FH patients in the United Kingdom","volume":"33","author":"Webb","year":"1992","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2015.09.029","article-title":"Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes","volume":"243","author":"Thompson","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9149(97)89309-5","article-title":"Relation of cholesterol-year score to severity of calcific atherosclerosis and tissue deposition in homozygous familial hypercholesterolemia","volume":"77","author":"Schmidt","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib23","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.atherosclerosis.2017.01.015","article-title":"Long-term outcome in 53 patients with homozygous familial hypercholesterolaemia in a single centre in France","volume":"257","author":"Bruckert","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib24","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Homozygous autosomal dominant hypercholesterolaemia in The Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib25","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/01.ATV.8.4.348","article-title":"Enhanced macrophage uptake of low density lipoprotein after self-aggregation","volume":"8","author":"Khoo","year":"1988","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib26","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/eurheartj\/ehx317","article-title":"Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol","volume":"39","author":"Thompson","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.atherosclerosis.2015.01.007","article-title":"Impact of LDL apheresis on aortic root atheroma in children with homozygous familial hypercholesterolemia","volume":"239","author":"Lefort","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib28","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1073\/pnas.78.4.2591","article-title":"Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in\u00a0vivo","volume":"78","author":"Thompson","year":"1981","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1 Suppl","key":"10.1016\/j.atherosclerosis.2018.07.032_bib29","first-page":"1152","article-title":"Plasmapheresis in familial hypercholesterolemia","volume":"9","author":"Thompson","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib30","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib31","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.jacc.2015.09.087","article-title":"Increased aortic valve calcification in familial hypercholesterolemia","volume":"66","author":"ten Kate","year":"2015","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib32","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1136\/bmj.283.6303.1358","article-title":"Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with familial hypercholesterolaemia","volume":"283","author":"Sugrue","year":"1981","journal-title":"Br. Med. J."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib33","first-page":"61","article-title":"The extracranial carotid artery in familial hypercholesterolaemia: relationship of intimal-medial thickness and plaque morphology with plasma lipids and coronary heart disease","volume":"3","author":"Sidhu","year":"1996","journal-title":"J.\u00a0Cardiovasc. Risk"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib34","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJM199705013361809","article-title":"The composition of coronary-artery plaques","volume":"336","author":"Davies","year":"1997","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib35","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/01.CIR.49.3.476","article-title":"Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia","volume":"49","author":"Stone","year":"1974","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib36","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","volume":"303","author":"Scientific Steering Committee on behalf of the Simon Broome Register Group","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib37","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.atherosclerosis.2012.02.043","article-title":"Detection of subclinical atherosclerosis in familial hypercholesterolemia using non-invasive imaging modalities","volume":"222","author":"Caballero","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib38","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/hrt.65.6.302","article-title":"Atherosclerosis: inhibition or regression as therapeutic possibilities","volume":"65","author":"Davies","year":"1991","journal-title":"Br. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2013.08.030","article-title":"Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins","volume":"231","author":"Shiomi","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib40","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1161\/01.ATV.14.7.1066","article-title":"Detection and quantitation of calcific atherosclerosis by ultrafast computed tomography in children and young adults with homozygous familial hypercholesterolemia","volume":"14","author":"Hoeg","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib41","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jacl.2017.03.016","article-title":"Early coronary calcifications are related to cholesterol burden in heterozygous familial hypercholesterolemia","volume":"11","author":"Gallo","year":"2017","journal-title":"J\u00a0Clin Lipdol"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib42","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.01.036","article-title":"Impact of statins on serial coronary calcification during atheroma progression and regression","volume":"65","author":"Puri","year":"2015","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jey012","article-title":"Impact of statin therapy on coronary plaque burden and composition assessed by coronary computed tomographic angiography: a systematic review and meta-analysis","author":"Andelius","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9150(98)00200-7","article-title":"Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management","volume":"142","author":"Scientific Steering Committee on behalf of the Simon Broome Register Group","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib45","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib46","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib47","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199011083231901","article-title":"Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B","volume":"323","author":"Brown","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib48","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-119-10-199311150-00002","article-title":"Coronary angiographic changes with lovastatin therapy. The monitored atherosclerosis regression study (MARS)","volume":"119","author":"Blankenhorn","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib49","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/01.CIR.89.3.959","article-title":"Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial","volume":"89","author":"Waters","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(94)92082-6","article-title":"Effect of simvastatin on coronary atheroma: the Multicentre anti-atheroma study (MAAS)","volume":"344","author":"Investigators","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib51","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1001\/jama.1990.03450230043027","article-title":"Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens","volume":"264","author":"Kane","year":"1990","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib52","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(95)92961-4","article-title":"The familial hypercholesterolaemia regression study: a randomised trial of LDL apheresis","volume":"345","author":"Thompson","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib53","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.93.10.1826","article-title":"LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis","volume":"93","author":"Kroon","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib54","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0021-9150(98)00328-1","article-title":"Effects of intensive lipid lowering by low-density lipoprotein apheresis on regression of coronary atherosclerosis in patients with familial hypercholesterolemia: Japan Low-density Lipoprotein Apheresis Coronary Atherosclerosis Prospective Study (L-CAPS)","volume":"144","author":"Nishimura","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib55","first-page":"1566","article-title":"Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering","volume":"319","author":"Navarese","year":"2018","journal-title":"A\u00a0Systematic Review and Meta-analysis. JAMA"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib56","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ahj.2014.07.028","article-title":"Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial","volume":"168","author":"Schwartz","year":"2014","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib57","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.amjcard.2017.12.040","article-title":"Efficacy and safety of alirocumab in high-risk patients with clinical atherosclerotic cardiovascular disease and\/or heterozygous familial hypercholesterolemia (from 5 placebo-controlled ODYSSEY trials)","volume":"121","author":"McCullough","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib58","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/ATVBAHA.114.303720","article-title":"CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects","volume":"34","author":"Gille","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib59","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1161\/CIRCULATIONAHA.116.025687","article-title":"Safety and tolerability of CSL 112, a reconstituted, infusible, plasma-derived apolipoprotein A-!, after acute myocardial infarction: the AEGIS-1 trial (ApoA-1 Event Reducing in Ischemic Syndromes 1)","volume":"134","author":"Gibson","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3181\/00379727-92-22510","article-title":"Independence of phosphatide induced hypercholesteremia and hepatic function","volume":"92","author":"Byers","year":"1956","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib61","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11886-018-1004-9","article-title":"HDL mimetics infusion and regression of atherosclerosis: is it still considered a valid therapeutic option?","volume":"20","author":"Karalis","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.atherosclerosis.2018.07.032_bib62","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur. Heart J."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018312395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018312395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T05:41:03Z","timestamp":1661665263000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018312395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":62,"alternative-id":["S0021915018312395"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.07.032","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atherosclerosis in cholesterol-fed rabbits and in homozygous and heterozygous LDL receptor-deficient humans","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}